Here are six quick facts:
1. Eight analysts gave the company a “strong buy” rating.
2. Nine analysts rated HCA a “buy.”
3. HCA received a “neutral” rating from 7 analysts.
4. The company has a 50-day moving average of $67.29, with a 200-day moving average of $73.10.
5. The market cap hit $28.09 billion.
6. HCA has a 52-week low of $43.91, with a 52-week high of $95.49.
More articles on transactions & valuation:
National Spine & Pain Centers opens center in Virginia: 5 notes
What’s new in selling ASC real estate, and ASC strategic partnerships?
SCA short interest falls 2%: 5 notes
